Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 25;115(12):2508-19.
doi: 10.1182/blood-2009-06-225631. Epub 2010 Jan 20.

Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns

F Lennie Wong  1 , Liton Francisco, Kayo Togawa, Alysia Bosworth, Mitzi Gonzales, Cara Hanby, Melanie Sabado, Marcia Grant, Stephen J Forman, Smita Bhatia
Affiliations

Long-term recovery after hematopoietic cell transplantation: predictors of quality-of-life concerns

F Lennie Wong et al. Blood. .

Abstract

This prospective longitudinal study examined the quality of life (QOL) after hematopoietic cell transplantation (HCT) and identified risk factors of poor QOL in 312 adult autologous and allogeneic HCT patients. Physical, psychological, social, and spiritual well-being was assessed before HCT, 6 months, and 1, 2, and 3 years after HCT. For all HCT patients, physical QOL was stable from before to after HCT (P > .05); psychologic (P < .001), social (P < .001), and spiritual (P = .03) QOL improved at 6 months. Study noncompleters (because of illness or death) had worse QOL. Allogeneic patients reported worse physical and psychologic well-being (P < .05). Older patients reported worse physical but better social well-being regardless of HCT type (P < .05). Two or more domains were affected by race/ethnicity, household income, and education in autologous patients, and by body mass index (BMI), decline in BMI, primary diagnosis, and chronic graft-versus-host disease (GVHD) in allogeneic patients (P < .05). At 3 years, 74% of HCT patients were employed full or part time. Older autologous patients with lower pre-HCT income were less likely to work (P < .05); allogeneic patients with chronic GVHD were less likely to work (P = .002). Multidisciplinary efforts to identify and support vulnerable subgroups after HCT need to be developed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow chart of study enrollment and participation.
Figure 2
Figure 2
GEE estimates of the longitudinal trends of QOL domains for autologous and allogeneic HCT patients combined (solid lines), and for autologous (dotted lines) and allogeneic (dashed lines) patients separately. ○ indicates observed means for autologous HCT patients; and ●, observed means for allogeneic HCT patients.
Figure 3
Figure 3
Pattern mixture model estimates of GEE longitudinal trends. Graphs show GEE longitudinal trends of QOL domains (broken lines) and observed means (symbols) by survival/completer status and GEE longitudinal trends for all patients combined (solid lines).
Figure 4
Figure 4
Proportion of HCT patients returning to work. Graphs show proportions of HCT patients returning to full- or part-time work by time since HCT according to (A) part-time or full-time status; (B) stem cell source; and (C) chronic GVHD status in allogeneic HCT recipients.
See this image and copyright information in PMC

References

    1. Marcelo P, Wang Z, Schneider L. Report on state of the art in blood and marrow transplantation: part I, CIBMTR summary slides. CIBMTR Newsl. 2007;13:5–8.
    1. Wingard JR, Vogelsang GB, Deeg HJ. Stem cell transplantation: supportive care and long-term complications. Hematology Am Soc Hematol Educ Program. 2002:422–444. - PubMed
    1. Bhatia S, Francisco L, Carter A, et al. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study [see comment]. Blood. 2007;110(10):3784–3792. - PMC - PubMed
    1. Bhatia S, Robison LL, Francisco L, et al. Late mortality in survivors of autologous hematopoietic-cell transplantation: report from the Bone Marrow Transplant Survivor Study. Blood. 2005;105(11):4215–4222. - PMC - PubMed
    1. Armenian SH, Sun C-L, Francisco L, et al. Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol. 2008;26(34):5537–5543. - PMC - PubMed

Publication types

MeSH terms